Heartburn medications do not ease asthma symptomsApril 09, 2009St. Louis, MO -- The predominance of heartburn among asthma sufferers led many specialists to suspect that acid reflux could be a trigger for the coughing, wheezing and breathlessness of asthma. In fact, it has become standard practice to prescribe heartburn medication to people with poorly controlled asthma, even if they don't have overt acid reflux symptoms. But a new study of adults with inadequate asthma control without significant heartburn shows that heartburn medication does not help control their asthma symptoms. The study, conducted by the American Lung Association's Asthma Clinical Research Centers at 20 U.S. sites, is the most comprehensive to date. It demonstrated that participants who took esomeprazole (Nexium) had as many asthma episodes as participants who were given an inactive pill, or placebo. The findings will appear April 9, 2009, in the New England Journal of Medicine. "This study goes against the idea that mild or silent acid reflux contributes to uncontrolled asthma," says Mario Castro, M.D., a Washington University pulmonary specialist at Barnes-Jewish Hospital who led the study in St. Louis. "It establishes that heartburn medications are not indicated for adults with uncontrolled asthma when they have mild or no symptoms of acid reflux." However, Castro says prescription heartburn medication is still indicated for those with severe heartburn and poorly controlled asthma because it might improve asthma control in some of these patients. The practice of prescribing heartburn medication to patients with poorly controlled asthma was a product of common sense - not only did asthma patients often suffer from heartburn, doctors had evidence that stomach acid traveling up the esophagus could get into the lungs and cause coughing. In addition, studies in laboratory animals showed that if the lower esophagus is exposed to acid, it could send nerve signals that loop back to the lungs and cause airway constriction. But, past investigations into the potential benefit of heartburn medication for asthma control were inconclusive, showing either no effect or a small benefit. The current study enrolled 412 patients who had poorly controlled asthma despite being treated with inhaled corticosteroids. But they had either no or very mild acid reflux symptoms. Each participant was randomly assigned to receive either 80 milligrams of esomeprazole or a placebo daily. Then for 24 weeks, they kept a daily record of their asthma symptoms. Every four weeks their lung function was tested, and they completed asthma questionnaires. In both the placebo and treatment groups, episodes of poor asthma control occurred with similar frequency. Occurrences of an urgent care visit for an asthma attack; a reduction in lung function; a course of corticosteroids, which reduce inflammation; or increased use of bronchodilators, which relax the airway muscles, did not differ significantly between the treatment and placebo groups. Night awakening due to asthma occurred on one or more occasions in about half of the participants, and the rate did not differ significantly between the two groups. "Despite using four-times the typical dose of the heartburn medication, we achieved no improvement in asthma symptoms, control or exacerbation rates," says Castro, also professor of medicine and pediatrics in the Division of Pulmonary and Critical Care Medicine. Although the participants were mostly free of heartburn symptoms, when the researchers measured acid reflux using probes placed in the esophagus for 24 hours, they found that about 40 percent of the study participants had some acid reflux. But even the participants with measureable acid reflux did not achieve greater control of their asthma when they received esomeprazole. The multicenter network is currently conducting a parallel study in children ages 6 to 17 who have poorly controlled asthma and no heartburn. Called SARCA (Studying Acid Reflux in Children with Asthma), the investigation will try to determine whether heartburn medication can help control asthma in younger patients. "Acid reflux is fairly common in children," Castro says. "And we know that a finding in adults doesn't necessarily apply to children, so we feel it's important to evaluate whether acid suppression in children with uncontrolled asthma is effective." Washington University School of Medicine |
|||||||||||||||||||||
| Related Heartburn Current Events and Heartburn News Articles Reflux esophagitis due to immune reaction, not acute acid burn, UT Southwestern researchers report Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study. Surgeons at Boston Medical Center offering new procedure for acid reflux/GERD Boston Medical Center (BMC) surgeons are now offering patients an incisionless alternative to laparoscopic and traditional surgery for treatment of acid reflux or GERD. Extra care for outwardly healthy workers costs companies millions annually Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs. Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers H2 Blocker drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the U.S. for acid reflux (heartburn), pose no significant risks for the fetus according to a large collaborative cohort study by researchers at Ben-Gurion University of the Negev. Major clinical study rejects cancer safety fears of most common heartburn treatment Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use. Care-seeking behavior associated with 'upper-GI symptoms' Patients with upper gastrointestinal (GI) complaints visit their general practitioner (GP) more often than patients with other conditions. National guideline released for the treatment of hoarseness The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue the first--and only--national clinical practice guideline to help healthcare practitioners identify and manage patients with hoarseness, also known as dysphonia. GERD negatively impacts sleep quality, results in considerable economic burden There has been much debate about the relationship between gastroesophageal reflux disease (GERD) and sleep. GERD patient satisfaction hinges on medication type and physician bedside manner Patient satisfaction with their medications and the quality of interactions with their doctor reflect the success of gastroesophageal reflux disease (GERD) therapy, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. NYU Langone Medical Center researchers find altered micriobiome prevalent in the diseased esophagus Gastroesophageal reflux diseases , or GERD, affects about 10 million people in the United States, yet the cause and an unexpected increase in its prevalence over the last three decades remains unexplainable. More Heartburn Current Events and Heartburn News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||